Small MoleculesJan 31, 2026
Process Simulation Platform: Enabling Process Development and Scale-up of Active Pharmaceutical Ingredients
Porton Crystallization team has the capability to perform process simulation of unit operations, including solvent swap, crystallization, filtration and drying.
Small MoleculesJan 15, 2026
A Decisive Milestone for On-time, On-budget Project Delivery
This case study demonstrates how rigorous analytical logic, disciplined execution, and targeted experimentation can resolve complex chromatographic challenges.
Small MoleculesDec 08, 2025
Optimizing Process Chemistry for Enhanced Pharmaceutical Manufacturing
Process Chemistry Optimization | Pharma Manufacturing
Small MoleculesOct 30, 2025
Expert Q&A: How to Efficiently Apply Preparative Chromatography in Drug Research
How to Efficiently Apply Preparative Chromatography in Drug Research
Small MoleculesSep 24, 2025
Biocatalysis: A Powerful and Possible Greener Tool for Chemists in the Pharmaceutical Industry
End-to-end Enzyme Solutions Efficient Screening & process Development Comprehensive Quality Control Extensive Successful Applications Cases Technological Innovation Enabled Cost Savings
Small MoleculesSep 23, 2025
Expert Q&A: Molecular Simulation and Data Science Support of Porton
Explore virtual screening duration, differences from property optimization, and crystal structure requirements for impurity rejection calculations.
Small MoleculesAug 14, 2025
Selecting the Right Solid Form-Faster, Smarter, Better
At Porton J-Star, we employ an integrated approach to identify and select the most suitable solid form for development (Figure 2). We conduct effective screen and rigorous assessments for polymorphs, salts, cocrystals, as well as amorphous solid dispersions, by applying our comprehensive expertise and experience.
Small MoleculesJul 21, 2025
Fast and Efficient：Significant Cost Reduction of a Starting Material
3 parallel chemical reactions, controlled crystallization process. Successful preparation, purification and characterization of all relevant impurities. High quality product. Successful development of relevant analytical methods. Successful cross-team and cross-site collaboration.
Small MoleculesJun 27, 2025
Multiple Approaches to Address the Challenges of Oral Absorption of PROTAC Drugs
As a global CDMO serving global innovative pharmaceutical companies and research institutions, Porton has an extensive experience in research and manufacturing services, especially in the field of PROTAC drug development. Porton is committed to the development and production of PROTAC oral formulations and provides customers with comprehensive, reliable, fast, and compliant one-stop services, to meet customers' supply chain needs and facilitating the commercial success of their products from research and development to order fulfillment.
